Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer

Cancer

Volumn 115, Issue 13, 2009, Pages 3009-3015

  Rizzo, Monica ^a,b,e   Lund, Mary Jo ^b,c   Mosunjac, Marina ^b   Bumpers, Harvey ^d   Holmes, Leslie ^b   O'Regan, Ruth ^a,b   Brawley, Otis W ^a,b   Gabram, Sheryl ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

African American; Chemotherapy; Locally advanced breast cancer; Race ethnicity; Radiation therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ADVANCED CANCER; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CANCER THERAPY; CLINICAL FEATURE; FEMALE; HEALTH CARE PLANNING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARRIAGE; MASTITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT REFUSAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 67649621601     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24334     Document Type: Article

References (21)

1. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol. 2003;21:2254-2259.
2. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272:947-954.
3. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114-123. (Pubitemid 30027686)
4. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998;82:1310-1318. (Pubitemid 28155393)
5. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491. (Pubitemid 29424554)
6. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008;109: 545-557. (Pubitemid 351692062)
7. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med. 2007;131:18. (Pubitemid 46174133)
8. Aziz H, Hussain F, Sohn C, et al. Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 1999;22:436-440. (Pubitemid 30263286)
9. Henson DE, Chu KC, Levine PH. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer. 2003;98:908-917. (Pubitemid 37022089)
10. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712. (Pubitemid 24138977)
11. Mohla S, Sampson CC, Khan T, Enterline JP, Leffall L Jr, White JE. Estrogen and progesterone receptors in breast cancer in Black Americans: correlation of receptor data with tumor differentiation. Cancer. 1982;50:552-559.
12. Chen VW, Correa P, Kurman RJ, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3:127-135. (Pubitemid 24170054)
13. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for 8 racial/ethnic groups. Cancer. 2001; 92:37-45. (Pubitemid 32623038)
14. Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009;113: 357-370.
15. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2502. (Pubitemid 43854964)
16. Haga SB, Fu S, Karp JE, et al. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia. 2000;14:1867-1875. (Pubitemid 30821581)
17. Fu S, Stevenson H, Strovel JW, et al. Distinct functions of 2 isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene. 2001;278:131-139. (Pubitemid 33055787)
18. Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004;100:2533-2542.
19. Kaufmann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol. 2003;21:2600-2608. (Pubitemid 46606344)
20. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81:21-31. (Pubitemid 37108437)
21. Gabram SG, Lund MJ, Gardner J, et al. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer. 2008;113: 602-607.